Patient Association: Children with Oncohematologic Diseases(Bulgaria): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
'''Access to information''': [https://www.decaohz.org/en/about-us/about-the-association/?utm_source=chatgpt.com Click here to learn more]. | '''Access to information''': [https://www.decaohz.org/en/about-us/about-the-association/?utm_source=chatgpt.com Click here to learn more]. | ||
<span style="display:none">Blood</span> | |||
<span style="display:none">Bone marrow</span> | |||
<span style="display:none">Lymph nodes</span> | |||
<span style="display:none">Spleen</span> | |||
<span style="display:none">Thymus gland</span> | |||
<span style="display:none">Leukemia</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
<span style="display:none">Lymphatic</span> | <span style="display:none">Lymphatic</span> | ||
<span style="display:none">Lymphoid</span> | <span style="display:none">Lymphoid</span> | ||
<span style="display:none">Hematologic</span> | <span style="display:none">Hematologic</span> | ||
<span style="display:none">Hematopoietic</span> | <span style="display:none">Hematopoietic</span> | ||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
Latest revision as of 20:21, 24 January 2026
Go back to Bulgaria page
Primary purpose: Is a parent-founded public-benefit organization in Bulgaria that supports children with cancer and their families through information, psychosocial care, education access during treatment, and long-term reintegration support. It also advocates for children’s rights and provides services via its “Golden Ribbon” daily center and survivor programs, so no child or family faces cancer alone.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system.
Access to information: Click here to learn more.
